Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subbaramaiah, K.
Right arrow Articles by Dannenberg, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subbaramaiah, K.
Right arrow Articles by Dannenberg, A. J.
[Cancer Research 62, 2522-2530, May 1, 2002]
© 2002 American Association for Cancer Research


Carcinogenesis

Retinoids and Carnosol Suppress Cyclooxygenase-2 Transcription by CREB-binding Protein/p300-dependent and -independent Mechanisms1

Kotha Subbaramaiah2, Philip A. Cole and Andrew J. Dannenberg

Department of Medicine, New York Presbyterian Hospital-Cornell and Strang Cancer Prevention Center, New York, New York 10021 [K. S., A. J. D.], and Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 [P. A. C.]

Treatment with retinoic acid (RA) or carnosol, two structurally unrelated compounds with anticancerproperties, inhibited phorbol ester (PMA)-mediated induction of activator protein-1 (AP-1) activity and cyclooxygenase-2 (COX-2) expression in human mammary epithelial cells. The induction of COX-2 transcription by PMA was mediated by increased binding of AP-1 to the cyclic AMP response element (CRE) of the COX-2 promoter. Inhibition of the histone acetyltransferase activity of CREB- binding protein (CBP)/p300 blocked the induction of COX-2 by PMA. Treatment with carnosol but not RA blocked increased binding of AP-1 to the COX-2 promoter. Because AP-1 binding was unaffected by RA, we investigated whether RA inhibited COX-2 transcription via effects on the coactivator CBP/p300. Treatment with RA stimulated an interaction between RA receptor-{alpha} and CBP/p300; a corresponding decrease in the interaction between CBP/p300 and c-Jun was observed. Importantly, overexpressing CBP/p300 or dominant-negative RA receptor-{alpha} relieved the suppressive effect of RA on PMA-mediated stimulation of the COX-2 promoter. To elucidate the mechanism by which carnosol inhibited COX-2 transcription, its effects on protein kinase C (PKC) signaling were determined. Carnosol but not RA inhibited the activation of PKC, ERK1/2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinase. Overexpressing c-Jun but not CBP/p300 reversed the suppressive effect of carnosol on PMA-mediated stimulation of COX-2 promoter activity. Thus, RA acted by a receptor-dependent mechanism to limit the amount of CBP/p300 that was available for AP-1-mediated induction of COX-2. By contrast, carnosol inhibited the induction of COX-2 by blocking PKC signaling and thereby the binding of AP-1 to the CRE of the COX-2 promoter. Taken together, these results show that small molecules can block the activation of COX-2 transcription by distinct mechanisms.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Subbaramaiah, C. Hudis, S.-H. Chang, T. Hla, and A. J. Dannenberg
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE
J. Biol. Chem., February 8, 2008; 283(6): 3433 - 3444.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. J. Tyson-Capper, D. M.W. Cork, E. Wesley, E. A. Shiells, and A. D. Loughney
Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy
Mol. Hum. Reprod., November 1, 2006; 12(11): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Eisinger, L. D. Nadauld, D. N. Shelton, P. W. Peterson, R. A. Phelps, S. Chidester, D. M. Stafforini, S. M. Prescott, and D. A. Jones
The Adenomatous Polyposis Coli Tumor Suppressor Gene Regulates Expression of Cyclooxygenase-2 by a Mechanism That Involves Retinoic Acid
J. Biol. Chem., July 21, 2006; 281(29): 20474 - 20482.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Yan, J. Li, W. Ouyang, Q. Ma, Y. Hu, D. Zhang, J. Ding, Q. Qu, K. Subbaramaiah, and C. Huang
NFAT3 is specifically required for TNF-{alpha}-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells
J. Cell Sci., July 15, 2006; 119(14): 2985 - 2994.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Sharma-Walia, H. Raghu, S. Sadagopan, R. Sivakumar, M. V. Veettil, P. P. Naranatt, M. M. Smith, and B. Chandran
Cyclooxygenase 2 Induced by Kaposi's Sarcoma-Associated Herpesvirus Early during In Vitro Infection of Target Cells Plays a Role in the Maintenance of Latent Viral Gene Expression.
J. Virol., July 1, 2006; 80(13): 6534 - 6552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ding, R. Feng, S. Y. Wang, L. Bowman, Y. Lu, Y. Qian, V. Castranova, B.-H. Jiang, and X. Shi
Cyanidin-3-glucoside, a Natural Product Derived from Blackberry, Exhibits Chemopreventive and Chemotherapeutic Activity
J. Biol. Chem., June 23, 2006; 281(25): 17359 - 17368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-M. Wang, C.-Y. Ko, L.-C. Chen, W.-L. Wang, and W.-C. Chang
Functional role of NF-IL6{beta} and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene
Nucleic Acids Res., January 5, 2006; 34(1): 217 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamaguchi, A. Lantowski, A. J. Dannenberg, and K. Subbaramaiah
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2
J. Biol. Chem., September 23, 2005; 280(38): 32569 - 32577.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Kong, H.-T. Kim, K. Wu, D. DeNardo, S. G. Hilsenbeck, X.-C. Xu, W. W. Lamph, R. Bissonnette, A. J. Dannenberg, and P. H. Brown
The Retinoid X Receptor-Selective Retinoid, LGD1069, Down-regulates Cyclooxygenase-2 Expression in Human Breast Cells through Transcription Factor Crosstalk: Implications for Molecular-Based Chemoprevention
Cancer Res., April 15, 2005; 65(8): 3462 - 3469.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. R. Bean, V. Scott, L. Yee, B. Ratliff-Daniel, M. M. Troch, P. Seo, M. L. Bowie, P. K. Marcom, J. Slade, B. F. Kimler, et al.
Retinoic Acid Receptor-{beta}2 Promoter Methylation in Random Periareolar Fine Needle Aspiration
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 790 - 798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Moraitis, B. Du, M. S. De Lorenzo, J. O. Boyle, B. B. Weksler, E. G. Cohen, J. F. Carew, N. K. Altorki, L. Kopelovich, K. Subbaramaiah, et al.
Levels of Cyclooxygenase-2 Are Increased in the Oral Mucosa of Smokers: Evidence for the Role of Epidermal Growth Factor Receptor and Its Ligands
Cancer Res., January 15, 2005; 65(2): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. L. Sabichi, V. Subbarayan, N. Llansa, S. M. Lippman, and D. G. Menter
Peroxisome Proliferator-Activated Receptor-{gamma} Suppresses Cyclooxygenase-2 Expression in Human Prostate Cells
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1704 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, G. L. Borchert, and J. M. Phang
Polyoma Enhancer Activator 3, an Ets Transcription Factor, Mediates the Induction of Cyclooxygenase-2 by Nitric Oxide in Colorectal Cancer Cells
J. Biol. Chem., April 30, 2004; 279(18): 18694 - 18700.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W.-G. Deng, Y. Zhu, and K. K. Wu
Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators
Blood, March 15, 2004; 103(6): 2135 - 2142.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Saha, K. R. Sekhar, C. Cao, J. D. Morrow, H. Choy, and M. L. Freeman
The Antiangiogenic Agent SU5416 Down-Regulates Phorbol Ester-Mediated Induction of Cyclooxygenase 2 Expression by Inhibiting Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity
Cancer Res., October 15, 2003; 63(20): 6920 - 6927.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. De Lorenzo, K. Yamaguchi, K. Subbaramaiah, and A. J. Dannenberg
Bryostatin-1 Stimulates the Transcription of Cyclooxygenase-2: Evidence for an Activator Protein-1-Dependent Mechanism
Clin. Cancer Res., October 15, 2003; 9(13): 5036 - 5043.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
D. O. McCarthy
Rethinking Nutritional Support for Persons with Cancer Cachexia
Biol Res Nurs, July 1, 2003; 5(1): 3 - 17.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Yeo, D. Gravis, J.-G. Yoon, and A.-K. Yi
Myeloid Differentiation Factor 88-dependent Transcriptional Regulation of Cyclooxygenase-2 Expression by CpG DNA: ROLE OF NF-{kappa}B AND p38
J. Biol. Chem., June 13, 2003; 278(25): 22563 - 22573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-G. Deng, Y. Zhu, and K. K. Wu
Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-alpha -induced Cyclooxygenase-2 Promoter Activation
J. Biol. Chem., February 7, 2003; 278(7): 4770 - 4777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.